All In Biotech

Drug Trial Radar · NCT05952089

A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart Failure

An Open-label, Single-sequence Study to Evaluate the Effect of Coadministration of Danicamtiv on the Pharmacokinetics of Midazolam in Patients With Stable Heart Failure With Reduced Ejection Fraction

Last checked: Nov 20, 2026Latest source record: Apr 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

13

Actual

Start

Aug 17, 2023

Primary completion

Mar 15, 2024

Study completion Mar 19, 2024

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Jul 19, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is assess the effect of danicamtiv, as an inducer on the drug levels of midazolam in participants with heart failure with reduced ejection fraction (HFrEF).

Conditions

  • Heart Failure With Reduced Ejection Fraction

Interventions

  • DanicamtivDrug

    Specified dose on specified days

  • MidazolamDrug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum observed plasma concentration (Cmax)Time frame: Up to Day 12
  2. Area under the plasma concentration time curve from time zero extrapolated to infinite time (AUC[INF])Time frame: Up to Day 12
  3. Area under the plasma concentration time curve from time zero to the time of the last quantifiable concentration (AUC[0-T])Time frame: Up to Day 12

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Holy Cross Hospital

    Fort Lauderdale, Florida

  • Nature Coast Clinical Research

    Inverness, Florida

  • Jacksonville Center For Clinical Research

    Jacksonville, Florida

  • Research Integrity LLC

    Owensboro, Kentucky

  • Sinai Hospital Of Baltimore

    Baltimore, Maryland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.